Sarah Whelan, PhD
Science Writer
at Technology Networks
Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.
Education
Areas of Expertise
Got a Question for Sarah Whelan, PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly.
Published Content
Total: 311
News
Beta-Blockers Linked to Depression for Some Heart Attack Patients
Commonly prescribed beta-blockers may increase the risk of depression for some patients who have had heart attacks, but also have a normal heart pumping ability, new research from Uppsala University suggests.
Industry Insight
How Can We Design Clinical Trials for Older People? We Asked an Expert
At ELRIG Drug Discovery 2024, Technology Networks sat down with Miles Witham, professor of trials for older people at Newcastle University, to learn more about these challenges and how novel approaches can be used to improve current research.
News
Glaucoma Drug Reduces Tau Buildup in Neurodegeneration Model
A common drug used to treat glaucoma has shown promise for neurodegenerative disease, preventing buildup of abnormal tau protein – implicated in dementia – in the brains of zebrafish and mice.
Industry Insight
AI and Bioengineering: How Biotech Start-Ups Are Driving Innovations in Drug Discovery
We reached out to start-ups at ELRIG Drug Discovery 2024 to see how AI and bioengineering can be applied in biotech and drug discovery.
News
Long-Theorized Waste-Clearing Pathway Uncovered in the Human Brain
The glymphatic system, a long-theorized waste-clearing pathway in the brain, has been revealed for the first time in humans, in a new study by Oregon Health and Science University (OSHU) researchers.
News
Sensory Prediction Under Anesthesia May Offer Clues About Conscious Cognition
A new study has examined how the brain constantly works to make predictions about what's happening in our surroundings during consciousness, and how this process breaks down under general anesthesia.
News
Brain Shrinkage Does Not Follow a Pattern in Alzheimer's
Brain shrinkage in people who develop Alzheimer’s disease follows no specific or uniform pattern, according to a new study from University College London (UCL) and Radboud University.
News
Largest-Ever Genetic Study on Epilepsy Uncovers Potential Therapeutic Paths
One of the largest and most diverse studies to date on genetic factors related to epilepsy has revealed potential new treatment targets.
Industry Insight
Innovation Award Winner Announced at ELRIG Drug Discovery 2024
Technology Networks had the pleasure of speaking with the ELRIG Innovation Award Winner Constructive Bio’s CEO, Dr. Ola Wlodek, to discuss its award-winning innovations and learn more about its mission.
Article
The Evolving Treatment Landscape for Alzheimer’s
We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving landscape of Alzheimer's treatments.
Advertisement
